Latest Cash Flow Reporting News

Page 21 of 37
Vonex Limited reports operational improvements, low complaint rates, and strategic executive hires in Q4 FY25, alongside a pivotal acquisition agreement with MaxoTel.
Sophie Babbage
Sophie Babbage
15 July 2025
Legend Mining Limited reported a stable cash flow for the June 2025 quarter, ending with nearly AUD 11.8 million in cash and equivalents and an estimated 32.7 quarters of funding available.
Maxwell Dee
Maxwell Dee
15 July 2025
Queste Communications reported a significant $3 million cash inflow in June 2025, driven by a royalty termination payment from its controlled entity, Orion Equities Limited, strengthening its liquidity position.
Claire Turing
Claire Turing
11 July 2025
ASX Compliance has formally questioned Rewardle Holdings Limited over delayed disclosures, financial inconsistencies, and governance concerns tied to its investments in Pepper Leaf, Beanhunter, and CloudHolter.
Victor Sage
Victor Sage
9 July 2025
Papyrus Australia reported a modest net operating cash outflow of $39,000 for May 2025, maintaining a solid cash position supported by available loan facilities that extend its funding runway to over 16 months.
Maxwell Dee
Maxwell Dee
27 June 2025
Queste Communications reported a $3 million inflow from an iron-ore royalty termination in May 2025, bolstering its cash reserves to over $4 million despite ongoing operating cash outflows.
Claire Turing
Claire Turing
5 June 2025
Papyrus Australia reported a $52,000 operating cash outflow for April 2025 but bolstered its liquidity with $239,000 in financing inflows, extending its funding runway to over a year.
Maxwell Dee
Maxwell Dee
30 May 2025
Queste Communications reported a strong cash inflow from investing activities in April 2025, driven by a $3 million receipt linked to the termination of an iron-ore royalty. The company ended the month with a robust cash position of over $4.1 million.
Claire Turing
Claire Turing
14 May 2025
Epsilon Healthcare reports ongoing operational challenges post-voluntary administration while unveiling a new pharmacy subsidiary aimed at diversifying revenue streams and rebuilding market confidence.
Ada Torres
Ada Torres
5 May 2025
Papyrus Australia has issued a revised Appendix 4C for the March 2025 quarter, correcting the treatment of $527k in R&D expenditure previously reported as cash payments. This adjustment also impacts prior monthly and quarterly cash flow reports dating back to November 2024.
Maxwell Dee
Maxwell Dee
5 May 2025
Cazaly Resources has issued a replacement Appendix 5B for the March 2025 quarter to correct an administrative error, reaffirming a solid cash position with over six quarters of funding available.
Maxwell Dee
Maxwell Dee
1 May 2025
Anagenics Limited reported a cash outflow of $424K for Q3 2025 but maintains robust liquidity with $1.48 million in available funding, supported by a mix of secured and unsecured loans.
Ada Torres
Ada Torres
1 May 2025